1 / 11

Aarkstore - Herpes Zoster (Shingles) - Pipeline Review, H2 2

“Herpes Zoster (Shingles) - Pipeline Review, H2 2014”, provides an overview of the Herpes Zoster (Shingles)s therapeutic pipeline. For more details : http://goo.gl/bm9QGG

Shubhangi
Télécharger la présentation

Aarkstore - Herpes Zoster (Shingles) - Pipeline Review, H2 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Aarkstore - Herpes Zoster (Shingles) - Pipeline Review, H2 2014 www.aarkstore.com

  2. Summary “Herpes Zoster (Shingles) - Pipeline Review, H2 2014”, provides an overview of the Herpes Zoster (Shingles)s therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Herpes Zoster (Shingles), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Zoster (Shingles) and special features on late-stage and discontinued projects. www.aarkstore.com www.aarkstore.com

  3. Scope - The report provides a snapshot of the global therapeutic landscape of Herpes Zoster (Shingles)- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Herpes Zoster (Shingles) and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Herpes Zoster (Shingles) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects- Coverage of the Herpes Zoster (Shingles) pipeline on the basis of target, MoA, route of administration and molecule type- Latest news and deals relating related to pipeline products www.aarkstore.com

  4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Herpes Zoster (Shingles)- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Herpes Zoster (Shingles) pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline www.aarkstore.com

  5. Table of Contents Introduction 6Global Markets Direct Report Coverage 6Herpes Zoster (Shingles) Overview 7Therapeutics Development 8Pipeline Products for Herpes Zoster (Shingles) - Overview 8Pipeline Products for Herpes Zoster (Shingles) - Comparative Analysis 9Herpes Zoster (Shingles) - Therapeutics under Development by Companies 10Herpes Zoster (Shingles) - Pipeline Products Glance 12Late Stage Products 12Clinical Stage Products 13Early Stage Products 14Unknown Stage Products 15Herpes Zoster (Shingles) - Products under Development by Companies 16Herpes Zoster (Shingles) - Companies Involved in Therapeutics Development 17GlaxoSmithKline plc 17 www.aarkstore.com

  6. List Of Tables Number of Products under Development for Herpes Zoster (Shingles), H2 2014 8Number of Products under Development for Herpes Zoster (Shingles) - Comparative Analysis, H2 2014 9Number of Products under Development by Companies, H2 2014 11Comparative Analysis by Late Stage Development, H2 2014 12Comparative Analysis by Clinical Stage Development, H2 2014 13Comparative Analysis by Early Stage Development, H2 2014 14Comparative Analysis by Unknown Stage Development, H2 2014 15Products under Development by Companies, H2 2014 16Herpes Zoster (Shingles) - Pipeline by GlaxoSmithKline plc, H2 2014 17Herpes Zoster (Shingles) - Pipeline by Merck & Co., Inc., H2 2014 18 www.aarkstore.com

  7. List Of Figures Number of Products under Development for Herpes Zoster (Shingles), H2 2014 8Number of Products under Development for Herpes Zoster (Shingles) - Comparative Analysis, H2 2014 9Number of Products under Development by Companies, H2 2014 10Comparative Analysis by Clinical Stage Development, H2 2014 13Assessment by Monotherapy Products, H2 2014 24Number of Products by Top 10 Target, H2 2014 25Number of Products by Stage and Top 10 Target, H2 2014 26Number of Products by Top 10 Mechanism of Action, H2 2014 27Number of Products by Stage and Top 10 Mechanism of Action, H2 2014 28Number of Products by Top 10 Route of Administration, H2 2014 29 www.aarkstore.com

  8. Related Market Research reports: • Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014 • Hematological Tumor - Pipeline Review, H1 2014 • Inflammation - Pipeline Review, H1 2014 • Opioid Induced Side Effects - Pipeline Review, H1 2014 • Skin Infections - Pipeline Review, H1 2014 www.aarkstore.com

  9. Related Market Research reports: • Restenosis - Pipeline Review, H1 2014 • Tauopathies - Pipeline Review, H1 2014 • Nasopharyngitis (Common Cold) - Pipeline Review, H1 2014 • Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H1 2014 • Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014 www.aarkstore.com

  10. Aarkstore - Herpes Zoster (Shingles) - Pipeline Review, H2 2014 www.aarkstore.com

  11. Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon,  Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614,  Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com

More Related